Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.

Data-driven subgroup allocations were generally consistent over follow-up and captured significant differences in risk factor trajectories, medication patterns and complication risks. Subgroups serve better as a complement rather than as a basis for compressing clustering indicators.